Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Would you ever turn to AI for companionship? 6% of Americans say they could — or already have. - 2Euclid space telescope sees gorgeous cosmic cloud | Space photo of the day for Nov. 18, 2025
- 3What is the Significant Tech Expertise to Master Today?
- 4From Overpowered to Coordinated: Individual Accounts of Cleaning up
- 5‘This year nearly broke me as a scientist’ – US researchers reflect on how 2025’s science cuts have changed their lives
- Lucrative Positions in the Advancing Position Market of 2024
- Activists: Venezuela released just nine prisoners despite promise
- Satellite space quiz: What's orbiting Earth?
- Make your choice for the sweet that transports you to its nation of beginning!
- UAE used military bases in Red Sea region to aid Israel's war against Hamas, leaks reveal
- Track down the Ideal Weight reduction Methodology for Your Way of life
- They relied on marijuana to get through the day. But then days felt impossible without it
- Former hostage Eitan Mor on Hamas: ‘They will not give up until the last Israeli is gone'
- A Gustav Klimt painting is now the most expensive piece of modern art sold at auction. The fascinating history behind the $236 million 'Portrait of Elisabeth Lederer.'
